Compare Oruka Therapeutics Inc. Common Stock (ORKA) vs PayPal Holdings, Inc. (PYPL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Oruka Therapeutics Inc. Common Stock vs PayPal Holdings, Inc. — how do they compare? Oruka Therapeutics Inc. Common Stock trades at $75.2 (market cap $5.18B), while PayPal Holdings, Inc. trades at $56.17 (market cap $48.05B). The key difference: PayPal Holdings, Inc. is far larger — about 9.3× Oruka Therapeutics Inc. Common Stock's market cap, and PayPal Holdings, Inc. pays a 1% dividend while Oruka Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Oruka Therapeutics Inc. Common Stock for 0 Days and PayPal Holdings, Inc. for 106 Days on average.
| ORKA | PYPL | |
|---|---|---|
Market Cap | $5.18B | $48.05B |
Volume | 490,798 | 7,905,570 |
Sector | Health | Financials |
52-Week High | $113.08 | $73.01 |
52-Week Low | $26.19 | $39.08 |
Typical Hold Time | 0 Days | 106 Days |
Enterprise Value | $4.31B | $50.20B |
Dividend Yield | — | 1% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
PayPal (PYPL) trades at $56.17, up 0.21% today, with a bullish technical signal from moving averages and oscillators. The stock shows strong fundamentals with a low P/E of 10.62 and robust profitability, including a 14.36% net income margin. Recent earnings beat expectations in Q1 and Q2 2026, and a new partnership with Meta announced on September 22, 2026, has boosted investor optimism. Cash flow remains healthy, with net cash flow of $1.53 billion in 2025.
The outlook for PayPal is cautiously optimistic, supported by valuation discounts and strategic initiatives under new CEO Enrique Lores. However, risks include competitive pressures in digital payments and slowing growth in branded checkout. Analyst consensus is a 'Hold' with a $56.41 price target, reflecting mixed sentiment amid turnaround efforts.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Oruka Therapeutics Inc. Common Stock
Oruka Therapeutics, Inc. is a clinical-stage biotechnology company developing extended half-life monoclonal antibodies for plaque psoriasis, psoriatic arthritis, and related dermatologic conditions, with lead candidates ORKA-001 and ORKA-002 in clinical trials.
Read more on ORKA →About PayPal Holdings, Inc.
PayPal Holdings, Inc. operates as a technology platform company that enables digital and mobile payments on behalf of consumers and merchants. The Company offers online payment solutions. PayPal Holdings serves customers worldwide.
Read more on PYPL →
